Cheri Taggart
Nurse Practitioner · Wheeling, WVNPI 1063583888
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,134, more than ten times the $15 reported in 2021. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$637
- Neurocrine Biosciences, Inc.$536
- Vanda Pharmaceuticals Inc.$490
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$335
- Teva Pharmaceuticals USA, Inc.$261
- Indivior Inc.$245
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,51499%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $637 |
| Neurocrine Biosciences, Inc. | 37 | $536 |
| Vanda Pharmaceuticals Inc. | 19 | $490 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $335 |
| Teva Pharmaceuticals USA, Inc. | 12 | $261 |
| Indivior Inc. | 13 | $245 |
| Johnson & Johnson | 8 | $176 |
| Lundbeck LLC | 9 | $157 |
| Alkermes, Inc. | 7 | $156 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Braeburn Inc. | 5 | $92 |
| Almatica Pharma LLC | 2 | $27 |
| Sage Therapeutics, LLC | 1 | $25 |
| Genentech USA, Inc. | 2 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$3,532 in reported general payments places this provider in the 90th percentile of 649 nurse practitioner providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 18 | $22,339 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 78 | $1,160 |
| Bupropion XlBupropion Hcl | 24 | $181 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 23 | $152 |
| Buspirone Hcl | 22 | $110 |
| Quetiapine Fumarate | 12 | $104 |
| Mirtazapine | 14 | $91 |
| Trazodone Hcl | 20 | $68 |
| Lamotrigine | 15 | $45 |
| Clonazepam | 22 | $43 |
| Lorazepam | 13 | $33 |
| Fluoxetine Hcl | 26 | $27 |
| Risperidone | 12 | $22 |
| Alprazolam | 12 | $7 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $176 | $22,33918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Wheeling
- Lacy HowardWheeling$18K
- Jane BowersWheeling$7K
- Carley ElswickWheeling$3K
- Leigh BrooksPrinceton$75K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
- Robin BlumeBeckley$18K
- Kellie VaughtBeckley$17K
- Lisa WalkerBeckley$17K
- Rachel BrillSouth Charleston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.